Cargando…
COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association
Autores principales: | Sookaromdee, Pathum, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213029/ https://www.ncbi.nlm.nih.gov/pubmed/32419754 http://dx.doi.org/10.4103/aian.AIAN_280_20 |
Ejemplares similares
-
COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
Dead Body of the Patient with COVID-19 and Concern on Disease Spreading
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
Spreading of COVID-19 in a Common Place: Medical Architecture Analysis
por: Sookaromdee, Pathum, et al.
Publicado: (2020)